Effect of Recombinant Human Interferon α-2b Spray on Herpangina

Herpangina Clinical Trial

Official title:
Effect and Safety of Recombinant Human Interferon α-2b Spray on Herpangina in Pediatric Patients

Status Completed

Clinical Trial Summary

This is a multicenter, open，randomized controlled trial aiming to evaluate the effectiveness of recombinant human interferon α-2b spray compared with ribavirin treatment on pediatric patients with herpangina.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Herpangina

Clinical Trial Details

NCT number	NCT03266601
Study type	Interventional
Source	Children's Hospital of Fudan University
Contact
Status	Completed
Phase	Phase 4
Start date	June 1, 2016
Completion date	December 31, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06063057` - Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial	Phase 1/Phase 2
Completed	`NCT03241030` - Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial	Phase 2
Recruiting	`NCT06263439` - Surveillance of HFMD in Pediatric Outpatients
Completed	`NCT01508247` - A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months	Phase 3